Home > Annual Financials > GENNEX LABORATORIES

GENNEX LABORATORIES Financial Statement Analysis
[BOM: 531739]

The Revenues of GENNEX LABORATORIES have increased by 32.18% YoY .
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 60.00 % YoY.
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Annual Financial Results
[BOM: 531739]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹87 Cr₹66 Cr₹61 Cr₹60 Cr₹56 Cr
Expenses ₹70 Cr₹61 Cr₹56 Cr₹53 Cr₹52 Cr
Operating Profit (Excl OI) ₹17 Cr₹4.69 Cr₹5.38 Cr₹6.53 Cr₹3.25 Cr
Other Income ₹4.91 Cr₹3.95 Cr₹1.38 Cr₹0.52 Cr₹0.95 Cr
Interest ₹3.08 Cr₹1.35 Cr₹0.88 Cr₹0.74 Cr₹0.75 Cr
Depreciation ₹2.37 Cr₹0.92 Cr₹0.79 Cr₹0.88 Cr₹1.01 Cr
Profit Before Tax ₹16 Cr₹6.37 Cr₹5.09 Cr₹5.06 Cr₹2.55 Cr
Profit After Tax ₹13 Cr₹4.92 Cr₹3.92 Cr₹4.04 Cr₹1.86 Cr
Consolidated Net Profit ₹11 Cr₹6.19 Cr₹4.11 Cr₹4.04 Cr₹1.86 Cr
Earnings Per Share (Rs)₹0.80₹0.50₹0.35₹0.32₹0.32
PAT Margin (%)11.6013.406.856.016.34
ROE(%)10.4910.777.959.3910.71
ROCE(%)12.4913.6410.1911.8213.24
Total Debt/Equity(x)0.130.120.220.230.19

Key Financials

Market Cap : ₹ 215.0 Cr
Revenue (TTM) : ₹ 183.1 Cr
Net Profit(TTM) : ₹ 20.6 Cr
EPS (TTM) : ₹ 0.8
P/E (TTM) : 10.4

Industry Peers & Returns1W1M1Y
GENNEX LABORATORIES -4.6% -13.9% -36.1%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -6.1% 5.5%
DIVIS LABORATORIES 0.9% -3.3% 39.2%
TORRENT PHARMACEUTICALS 0.1% -7.2% 28.2%
CIPLA -0.3% -4% -15.7%
DR REDDYS LABORATORIES 1.5% 3.1% 0.4%
MANKIND PHARMA -3.3% -6.3% -6.7%
LUPIN -1.6% -9.1% 0.8%
ZYDUS LIFESCIENCES -0.5% -2.3% 14.3%


GENNEX LABORATORIES Revenues
[BOM: 531739]

Y-o-Y

32.18 %

5 Yr CAGR

11.74 %

Years Revenues % Change
Mar2025 ₹87 Cr
32.18
Mar2024 ₹66 Cr
7.17
Mar2023 ₹61 Cr
2.62
Mar2022 ₹60 Cr
7.25
Mar2021 ₹56 Cr -


GENNEX LABORATORIES Operating Profit
[BOM: 531739]

Y-o-Y

262.88 %

5 Yr CAGR

51.33 %

Years Operating Profit % Change
Mar2025 ₹17 Cr
262.88
Mar2024 ₹4.69 Cr
-12.74
Mar2023 ₹5.38 Cr
-17.68
Mar2022 ₹6.53 Cr
101.20
Mar2021 ₹3.25 Cr -

Operating Margins
Y-o-Y

174.69 %

5 Yr CAGR

35.42 %

Years Operating Margin% % Change
Mar2025 19.64%
174.69
Mar2024 7.15%
-18.66
Mar2023 8.79%
-19.73
Mar2022 10.95%
87.50
Mar2021 5.84% -

GENNEX LABORATORIES Profit After Tax
[BOM: 531739]

Y-o-Y

83.61 %

5 Yr CAGR

57.33 %

Years Profit After Tax % Change
Mar2025 ₹11 Cr
83.61
Mar2024 ₹6.19 Cr
50.89
Mar2023 ₹4.11 Cr
1.66
Mar2022 ₹4.04 Cr
117.56
Mar2021 ₹1.86 Cr -

PAT Margins
Y-o-Y

-13.43 %

5 Yr CAGR

16.30 %

Years PAT Margin(%) % Change
Mar2025 11.6 %
-13.43
Mar2024 13.4 %
95.62
Mar2023 6.85 %
13.98
Mar2022 6.01 %
-5.21
Mar2021 6.34 % -

GENNEX LABORATORIES Earnings Per Share (EPS)
[BOM: 531739]

Y-o-Y

60.00 %

5 Yr CAGR

25.74 %

Years EPS % Change
Mar2025 ₹0.80
60.00
Mar2024 ₹0.50
42.86
Mar2023 ₹0.35
9.37
Mar2022 ₹0.32
0.00
Mar2021 ₹0.32 -

GENNEX LABORATORIES Return on Capital Employed (ROCE)
[BOM: 531739]

Y-o-Y

-8.43 %

5 Yr CAGR

-1.45 %

Years ROCE % Change
Mar2025 12.49%
-8.43
Mar2024 13.64%
33.86
Mar2023 10.19%
-13.79
Mar2022 11.82%
-10.73
Mar2021 13.24% -

GENNEX LABORATORIES Share Price vs Sensex

Current Share Price : ₹8.9
Current MarketCap: ₹ 215.0 Cr
Updated EOD on :Oct 22,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-4.6%

-13.9%

-36.1%

SENSEX

0.6%

-1.4%

-10.7%

GENNEX LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -2% -7.9% 6.7%
No NSE index found

You may also like the below Video Courses


FAQ about GENNEX LABORATORIES Financials


How the annual revenues of GENNEX LABORATORIES have changed ?

The Revenues of GENNEX LABORATORIES have increased by 32.18% YoY .

How the Earnings per Share (EPS) of GENNEX LABORATORIES have changed?

The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 60.00 % YoY .